Access Bio (XKRX:950130) Dividends per Share : ₩0.00 (TTM As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Access Bio Dividends per Share?

Access Bio's dividends per share for the three months ended in Mar. 2024 was ₩0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Access Bio's Dividend Yield % is 0.00%.

During the past 12 months, Access Bio's average Dividends Per Share Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

Access Bio Dividends per Share Historical Data

The historical data trend for Access Bio's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Access Bio Dividends per Share Chart

Access Bio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividends per Share

Get a 7-Day Free Trial

871.00

Access Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Access Bio's Dividends per Share

For the Diagnostics & Research subindustry, Access Bio's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Access Bio's Dividend Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Access Bio's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Access Bio's Dividend Yield % falls into.

Access Bio Dividends per Share Calculation

Dividends paid to per common share.

Access Bio (XKRX:950130) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Access Bio's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2024 )	/	EPS without NRI (Q: Mar. 2024 )
	=	0	/	86.1
	=	0.00

During the past 12 years, the highest Dividend Payout Ratio of Access Bio was 0.09. The lowest was 0.09. And the median was 0.09.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 12 years, the highest Dividend Yield of Access Bio was 11.49%. The lowest was 0.00%. And the median was 9.22%.

Access Bio Dividends per Share Related Terms

Thank you for viewing the detailed overview of Access Bio's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Access Bio (XKRX:950130) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Clyde Road, Suite A, Somerset, NJ, USA, 08873

Website

http://www.accessbio.net

Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Access Bio (XKRX:950130) Headlines

No Headlines